Avantor
Share
Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve.
07/26/2024
Today, Avantor reported our second quarter 2024 results. Our President and CEO, Michael Stubblefield, and EVP & CFO, R. Brent Jones, discuss our results. For more information, including our press release and presentation, visit https://ow.ly/E5rT50SL5Yl.
Monoclonal antibodies are powerful tools for fighting diseases that require complex and costly manufacturing processes. Optimize your scale-up strategy to your exact needs — from immediate improvements in large-volume handling, to long-term supply assurance of GMP quality chemicals.
03/14/2024
Discover how biopharma manufacturer and critical material supplier collaboration can ensure consistent quality of raw materials — minimizing supply chain risk and protecting patient safety.
See the data behind this best practice model at Jennifer Goodman's presentation, next week at DCAT.
02/22/2024
What does 2024 hold for biopharma? When Scrip asked Nandu Deorkar, our SVP of biopharma production R&D, how technology will transform biopharma, he identified manufacturing as likely to benefit from AI this year.
Click here to claim your Sponsored Listing.
Introducing Avantor
From breakthrough discovery to agile delivery of mission-critical products and services, we are a trusted global partner to customers in the life sciences and advanced technologies & applied materials industries. Learn how: avantorsciences.com
Address
100 Matsonford Road, Building One
Radnor, PA
19087
